Dual regulations of thermo-sensitive heparin-poloxamer hydrogel using ε-polylysine: Bioadhesivity and Controlled KGF release for enhancing wound healing of endometrial injury.

ydrogel was not only used as an effective support matrix to prevent intrauterine adhesion (IUA) after endometrial injury but also served as scaffold to sustain release of some therapeutics, especially growth factor. However, because of the rapid turnover of the endometrial mucus, the poor retention and bad absorption of therapeutic agents in damaged endometrial cavity were two important factors hindering their pharmacologic effect. Herein, a mucoadhesive hydrogel was described by using heparin-modified poloxamer (HP) as the matrix material and ε-polylysine (EPL) as functional excipient. Various EPL-HP hydrogels formulations are screened by rheological evaluation and mucoadhesion studies. It was found that the rheological and mucoadhesive properties of EPL-HP hydrogels were easily controlled by changing the amount of EPL in formulation. The storage modulus of EPL-HP hydrogel with 90μg/mL of EPL (HP-EPL-90) was elevated to be 1.9×105Pa, in accordance with the adhesion force rising up to 3.18N (10-fold higher than HP hydrogels). Moreover, in vitro release of model drug, keratinocyte growth factor (KGF), from EPL-HP hydrogel was significantly accelerated by adding ε-polylysine in comparison with HP hydrogel. Both of strong mucoadhesive ability and the accelerated drug release behavior for EPL-HP-90 made more the encapsulated KGF be absorbed by the uterus basal layer and endometrial glands after 8h of administration in uterus cavity. Meanwhile, the morphology of endometrium in the injured uterus was repaired well after 3days of treatment with KGF-EPL-HP-90 hydrogels. Compared with KGF-HP group, not only proliferation of endometrial epithelial cell and glands but also angiogenesis in the regenerated endometrium was obviously enhanced after treatment with KGF-EPL-HP-90 hydrogels. Alternatively, the cellular apoptosis in the damaged endometrium was significantly inhibited after treatment with KGF-EPL-HP-90 hydrogels. Overall, the mucoadhesive EPL-HP hydrogel with a suitable KGF release profile may be a more promising approach than HP hydrogel alone to repair the injured endometrium.